Shopping Cart
Remove All
Your shopping cart is currently empty
Edaglitazone (R-483) is an orally active, selective and potent PPARγ agonist showing affinity for both PPARα and PPARγ. Edaglitazone displays antiplatelet activity and can be used in studies of diabetes mellitus and obesity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $519 | 35 days | 35 days |
| Description | Edaglitazone (R-483) is an orally active, selective and potent PPARγ agonist showing affinity for both PPARα and PPARγ. Edaglitazone displays antiplatelet activity and can be used in studies of diabetes mellitus and obesity. |
| Targets&IC50 | PPARα:1053 nM (EC50), PPARγ:35.6 nM (EC50) |
| In vitro | METHODS: To elucidate the mechanism of the antiplatelet effect of edaglitazone, platelet cAMP levels were assessed using edaglitazone (3, 6, and 12 μM), Consistent with the aggregation assay, RESULTS: Edaglitazone increased platelet cAMP levels in a concentration-dependent manner, suggesting that its antiplatelet effect is partly mediated by the regulation of cAMP levels. [1] |
| Synonyms | R-483, Edaglitazone sodium, BM-13.1258 |
| Molecular Weight | 464.56 |
| Formula | C24H20N2O4S2 |
| Cas No. | 213411-83-7 |
| Smiles | O=C1SC(C(=O)N1)CC2=CC=C(OCCC=3N=C(OC3C)C=4C=CC=CC4)C=5C=CSC52 |
| Relative Density. | 1.374 g/cm3 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.